Atossa Genetics is a leader in developing innovative breast health products. Breast cancer is the most common non-skin cancer among women, and 1 in 8 women in the United States will develop the disease.1 Nearly 300,000 new cases of breast cancer are diagnosed each year and nearly 40,000 die of the disease annually.1 Atossa Genetics is committed to helping women understand their breast health.

Atossa Genetics was founded in 2009 and is located in Seattle, Washington. The company is named for Princess Atossa, the daughter of Cyrus the Great and the wife of Darius I, the King of the Achaemenid Empire. In about 470 BCE, Atossa became the first woman in recorded history to be diagnosed with breast cancer. While the disease has been with us for thousands of years, Atossa Genetics is committed to reducing its impact on women.

Reference:
1 Breast Cancer. American Cancer Society. Available at: http://www.cancer.org/
2 Chen SC, Vitkun SA, Quay. A Phase 1 Safety and Efficacy Study of the Mammary Aspirate Specimen Cytology Test Device for Collection of Specimens for Exfoliative Cytopathology of the Breast Ducts. Adv in Bioscience and Biotechnology. 2013; (4)846-852.